921 – 930 of 1188
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 1998
-
Mark
Dosage of adjuvant G-CSF (filgrastim)-supported FEC polychemotherapy based on equivalent haematological toxicity in high-risk breast cancer patients. Scandinavian Breast Group, Study SBG 9401
1998) In Annals of oncology : official journal of the European Society for Medical Oncology 9(4). p.403-411(
- Contribution to journal › Article
-
Mark
Dacarbazine-vindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A randomised phase III trial
(
- Contribution to journal › Article
-
Mark
Psychological profile related to malignant tumours of different histopathology
(
- Contribution to journal › Article
-
Mark
Attitude towards aggression and creative functioning in patients with breast cancer
(
- Contribution to journal › Article
-
Mark
Non-invasive investigation of endothelium-dependent dilatation of the brachial artery in women with primary Raynaud's phenomenon
(
- Contribution to journal › Article
-
Mark
Whole-body cooling increases plasma endothelin-1 levels in women with primary Raynaud's phenomenon
(
- Contribution to journal › Article
-
Mark
Diving response and apneic time in humans
(
- Contribution to journal › Article
-
Mark
Cardiovascular mortality among pituitary insufficient patients
(
- Contribution to journal › Letter
-
Mark
Persistent high prevalence of thyroid antibodies after immunosuppressive therapy in subjects with glomerulonephritis. A prospective three-year follow-up study
(
- Contribution to journal › Article
- 1997
-
Mark
Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer
(
- Contribution to journal › Article